Diagnostic and Monitoring Ophthalmic Devices and Equipment Market Report 2026

The diagnostic and monitoring ophthalmic devices and equipment market size has grown steadily in recent years. It will grow from $5.14 billion in 2025 to $5.39 billion in 2026 at a compound annual growth rate (CAGR) of 4.8%. The growth in the historic period can be attributed to increasing prevalence of eye disorders, growing aging population, expansion of ophthalmic diagnostic centers, rising awareness of preventive eye care, advancements in imaging technologies.

The diagnostic and monitoring ophthalmic devices and equipment market size is expected to see steady growth in the next few years. It will grow to $6.54 billion in 2030 at a compound annual growth rate (CAGR) of 5%. The growth in the forecast period can be attributed to increasing demand for early glaucoma and retinal disease detection, rising adoption of tele-ophthalmology solutions, expansion of smart diagnostic platforms, growing investments in precision eye care, increasing integration of ai-based analytics. Major trends in the forecast period include increasing adoption of ai-enabled ophthalmic diagnostics, rising demand for high-resolution retinal imaging systems, growing use of non-invasive vision monitoring devices, expansion of automated refraction and screening equipment, enhanced focus on early disease detection.

The increasing incidence of diabetes is expected to drive the growth of the diagnostic and monitoring ophthalmic devices and equipment market going forward. Diabetes is a long-term condition that arises when the body is unable to produce sufficient insulin or effectively utilize the insulin it produces to regulate blood glucose levels. The growing incidence of diabetes is largely attributed to widespread lifestyle changes, including unhealthy diets high in sugar and fat and reduced levels of physical activity. Diagnostic and monitoring ophthalmic devices and equipment, such as smart contact lenses, can be used for continuous glucose monitoring as well as for managing diabetic retinopathy. These devices are capable of wirelessly tracking glucose levels and delivering real-time data to users. For instance, in 2025, according to the International Diabetes Federation, a Belgium-based health organization, in 2024 approximately 589 million adults aged 20-79 were living with diabetes, and this number is projected to rise to 853 million by 2050, with more than four out of five adults with diabetes residing in low- and middle-income countries. Thus, the increasing incidence of diabetes is driving the growth of the diagnostic and monitoring ophthalmic devices and equipment market.

Major companies within the diagnostic and monitoring equipment segment of the ophthalmic devices market are focused on developing innovative solutions, such as the utilization of Smart contact lenses employing smart soft contact lens technology to enhance patient care. The use of smart soft contact lens technology is a recent advancement that allows for continuous monitoring of intraocular pressure (IOP) over a 24-hour period, particularly beneficial in glaucoma care. In January 2023, BVS Sight Inc., a US-based company, introduced Smart contact lenses using smart soft contact lens technology. These smart soft contact lenses are integrated with various existing commercial soft contact lens brands, preserving their essential properties, including lens power, biocompatibility, softness, transparency, wettability, oxygen transmissibility, and the ability for overnight wear.

In July 2024, Bausch + Lomb Corporation, a Canada-based eye-health company, acquired Trukera Medical for an undisclosed amount. Through this acquisition, Bausch + Lomb sought to expand its surgical footprint in the United States and reinforce its leadership position in the dry eye disease market by incorporating Trukera’s ScoutPro platform into its surgical and preoperative workflows. The ScoutPro platform is a portable, point-of-care device that quantitatively measures tear osmolarity by assessing the salt content of tears. Trukera Medical is a US-based ophthalmic diagnostics company specializing in tear-osmolarity testing and corneal surface disease diagnostics.

Major companies operating in the diagnostic and monitoring ophthalmic devices and equipment market are Carl Zeiss Meditec, Alcon Inc., Bausch + Lomb, Haag-Streit, Topcon Corporation, Nidek Co. Ltd., Abbott Medical Optics, Johnson and Johnson Vision Care, Essilor International S.A., Ziemer Ophthalmic Systems AG, Ellex, Quantel Medical Inc., Optovue, Canon Inc., Halma plc, Coburn Technologies Inc., Kowa Company Ltd., Hoya Corporation, Gulden Ophthalmics, Glaukos Corporation, Matronix India Corporation, HEINE Optotechnik, Visionix Ltd., Appasamy Associates, Ophtec BV, Lumenis, Ocular Instruments, Ophthalmic Instruments Company, Keeler Ltd., Oculus, Reichert Technologies, Tomey Corporation, US Ophthalmic.

North America was the largest region in the global diagnostic and monitoring ophthalmic devices and equipment market in 2025. Asia-Pacific was the second-largest region in diagnostic and monitoring ophthalmic devices and equipment market. The regions covered in the diagnostic and monitoring ophthalmic devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the diagnostic and monitoring ophthalmic devices and equipment market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

Tariffs are impacting the diagnostic and monitoring ophthalmic devices and equipment market by increasing costs of imported imaging sensors, optical components, electronic boards, and precision manufacturing tools used across OCT systems, fundus cameras, and tonometers. Hospitals and clinics in North America and Europe are most affected due to dependence on imported diagnostic equipment, while Asia-Pacific faces higher production costs for advanced devices. These tariffs are raising capital expenditure and delaying technology upgrades. However, they are also encouraging domestic production, localized assembly, and regional innovation in ophthalmic diagnostic solutions.

The diagnostic and monitoring ophthalmic devices and equipment market research report is one of a series of new reports that provides diagnostic and monitoring ophthalmic devices and equipment market statistics, including diagnostic and monitoring ophthalmic devices and equipment industry global market size, regional shares, competitors with a diagnostic and monitoring ophthalmic devices and equipment market share, detailed diagnostic and monitoring ophthalmic devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the diagnostic and monitoring ophthalmic devices and equipment industry. This diagnostic and monitoring ophthalmic devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Diagnostic and monitoring ophthalmic devices and equipment play a crucial role in the diagnosis and ongoing observation of retinal and corneal conditions, aiding in measuring refraction errors, identifying intraocular lenses (IOLs), and assessing the visual field.

Key product types in this segment include a range of equipment such as optical coherence tomographers, ophthalmic ultrasound imaging systems, fundus cameras, ophthalmoscopes, keratometers, specular microscopes, tonometers, slit lamps, retinoscopes, and others (including dioptometers, optotype projectors, perimeters, biometers, pachymeters, autorefractors/phoropters, corneal topographers, wavefront aberrometers). Fundus cameras are instrumental in rear-eye imaging for diagnostic and monitoring purposes, contributing significantly to applications like retinal evaluation, glaucoma detection and monitoring, surgical evaluations, general examinations, intraoperative devices, and refraction equipment. These ophthalmic devices are utilized across various settings, including hospitals, clinics, diagnostic laboratories, and research centers.

The Diagnostic and monitoring ophthalmic devices and equipment market consist of sales of ultrasound imaging systems ophthalmoscopes, corneal topographers, specular microscopes, slit lamps, fundus cameras, anomaloscope, haploscope, ophthalmic lens gauge, stereopsis measuring Instrument, retinoscopes, stereoscope, and others that are used for diagnosis and monitoring of ophthalmic diseases. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.